NCT03341702 is a clinical trial of penintetiary's incident reports collection in Prisoner, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT03341702?

NCT03341702 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT03341702?

Interventions in NCT03341702: penintetiary's incident reports collection.

Is NCT03341702 still recruiting?

NCT03341702 is currently completed. Last updated 7 May 2018.

Last reviewed 2018-05-07 · How we verify

NCT03341702

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predictive Factors of Violence in Prison

Completed Last updated 7 May 2018

What this trial tests

trial testing penintetiary's incident reports collection in Prisoner in 1,200 participants. Completed in 1 March 2018.

Timeline

1 April 2015

Primary endpoint
10 October 2017

1 March 2018

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,200
Start date	1 April 2015
Primary completion	10 October 2017
Estimated completion	1 March 2018
Sites	1 location across France

Drugs / interventions tested

penintetiary's incident reports collection

Conditions studied

Prisoner — all drugs for Prisoner →

Sponsor

University Hospital, Montpellier

Who can join

18 and older, male only, with Prisoner. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prison concentrates people with violent behavior and patients suffering from psychiatric disorders. Aggression are daily, the suicide rate is 5 to 10 times higher than the ordinary environment and current prevention devices have shown their limits. That's why, in order to improve the violence's prevention in prison, the investigator propose to identify the predictive factors of violence by studying retrospectively the link between the psychiatric profile and commission of violence after being jailed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03341702 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 7 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing